Concepedia

Richard T. Lewis

RT

Statistics

Publications

29

Citations

1K

H-Index

20

Active since

1988

Affiliations

MSD (UK) Limited (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Amgen (United States)

Imperial College London

Tesaro (United States)

Richard T. Lewis is an author at MSD (UK) Limited (United Kingdom) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1988–2021

29

Publications

29

Imidazo[1,2<i>-a</i>]pyrimidines as Functionally Selective and Orally Bioavailable GABA<sub>A</sub>α2/α3 Binding Site Agonists for the Treatment of Anxiety Disorders

Simon Goodacre, Leslie J. Street, David J. Hallett et al. · Journal of Medicinal Chemistry · 2005 · 132 citations · Full text

, , +17

Synthesis of a remarkably stable bicyclo[7.3.1]diynene esperamicin A1/calicheamicin .gamma. system. Structural requirements for facile formation of a 1,4-diyl

Philip Magnus, Richard T. Lewis, John C. Huffman · Journal of the American Chemical Society · 1988 · 104 citations

, , +6

Identification of potent and selective MTH1 inhibitors

Alessia Petrocchi, Elisabetta Leo, Naphtali J. Reyna et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 70 citations · Full text

, , +8

Tryptophan-Derived NK1 Antagonists: Conformationally Constrained Heterocyclic Bioisosteres of the Ester Linkage

Richard T. Lewis, Angus M. MacLeod, Kevin J. Merchant et al. · Journal of Medicinal Chemistry · 1995 · 58 citations · Full text

, , +14

Intramolecular palladium catalysed [3+2] cycloadditions of methylenecyclopropanes with acetylenic acceptors

Hervé Corlay, Richard T. Lewis, William B. Motherwell et al. · Tetrahedron · 1995 · 57 citations

, , +10

1–5 of 29